Clinical Trials Directory

Trials / Unknown

UnknownNCT05045287

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Phase II Study of Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
57 (estimated)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Hypofractionated radiotherapy could provide more convenient treatment and had similar toxicities.However,reports of hypofractionated radiotherapy with two-stage expander/implant reconstruction are rare,Some studies have shown that hypofractionated radiotherapy had similar toxicities to conventional fractionated radiotherapy in patients with breast reconstruction. So,investigators conducted a phase II study to observe the reconstruction failure in hypofractionated radiotherapy with two-stage expander/implant reconstruction.

Detailed description

Results from a phase III randomized controlled study in China showed that Postmastectomy hypofractionated radiotherapy was non-inferior to and had similar toxicities to conventional fractionated radiotherapy in patients with high-risk breast cancer.However,reports of hypofractionated radiotherapy with two-stage expander/implant reconstruction are rare. Literatures report that reconstruction failure is a well-known complication of radiation therapy in breast cancer patients with reconstruction. Results may vary based on RT timing and technique. Some studies have shown that hypofractionated radiotherapy had similar reconstruction failure to conventional fractionated radiotherapy in patients with breast reconstruction. So,investigators conducted a phase II study to observe the reconstruction failure in hypofractionated radiotherapy with two-stage expander/implant reconstruction.

Conditions

Interventions

TypeNameDescription
RADIATIONhypofractionated radiotherapyUndergo hypofractionated RT,obeserve reconstruction failure,cosmetic result and recurrence rate

Timeline

Start date
2021-04-08
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2021-09-16
Last updated
2021-09-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05045287. Inclusion in this directory is not an endorsement.